A human skin culture system that mimics human skin and replaces animal testing; an interactive map to help blind and visually impaired people to navigate safely around train stations and a flat-pack, solar collector offering affordable, clean energy for developing countries – these are just some of the trail-blazing ideas emerging from the pool of 2019 Converge participants. Carcinotech is one of the semi-finalists to join the Converge Cohort 2019.
Read the full article here
Read the full article here.
Life sciences business Carcinotech has agreed a partnership with Swedish firm Cellink to research treatments for brain
Carcinotech has secured £1.6 million in funding to accelerate commercialisation plans and expand
Carcinotech is a MedTech company with expertise in manufacturing 3D printed living tumours using patient-derived biopsies, primary cells, immune cells and cancer stem cells.
Subscribe to our newsletter to get the latest news, updates, and special offers.
